2016 The 25th meeting of the Standing Committee of the 12th National People's Congress in December# April deliberated and passed the "the People's Republic of China Law on Traditional Chinese Medicine" (hereinafter referred to as the "Law on Traditional Chinese Medicine"), which will come into effect on June 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine.

With the change of people's health concept and the continuous innovation of medical model in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge.

What will the Chinese Medicine Law bring us?

Reporter: As the general manager of Jianfeng Pharmaceutical, what do you think of the Chinese Medicine Law?

Golden Dragon (Deputy General Manager of the Group Company, General Manager of the Pharmaceutical Company): The Chinese Medicine Law clarifies the important position and development policy of Chinese medicine. The state encourages Chinese medicine and Western medicine to learn from each other, complement each other, and coordinate Development, give play to their respective advantages, and promote the integration of Chinese and Western medicine; Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease, has a long history of tradition and unique theory and technical methods. It is precisely because of the distinctive characteristics of traditional Chinese medicine that the Law of traditional Chinese Medicine has reformed and innovated the existing management system in many aspects, such as traditional Chinese medicine clinics, access to traditional Chinese medicine doctors, and management of traditional Chinese medicine, and stipulates a management system that adapts to the law of the development of traditional Chinese medicine and conforms to the characteristics of traditional Chinese medicine, therefore, the Law of traditional Chinese Medicine has further increased the support for the cause of traditional Chinese medicine; in view of the problems existing in the traditional Chinese medicine industry, such as non-standard services and the decline in the quality of traditional Chinese medicine, the Law of traditional Chinese Medicine has also made targeted provisions to strengthen the supervision of traditional Chinese medicine; clear legal responsibilities are stipulated for illegal acts such as illegal practice of Chinese medicine clinics and Chinese medicine doctors, illegal processing of Chinese medicine decoction pieces by medical institutions, illegal preparation of Chinese medicine preparations, and illegal publication of Chinese medicine medical advertisements, especially for the use of highly toxic and highly toxic in the process of planting Chinese medicinal materials. The illegal behavior of toxic pesticides has clarified severe penalties to ensure the safety of the people's medication.

Reporter: Does the promulgation of the new law have any influence on Jianfeng Pharmaceutical Industry? Is there any plan for the development of traditional Chinese medicine in the future?

Golden Dragon: The pharmaceutical company's product line mainly includes anti-infection, cardiovascular and anti-depression drugs, mainly chemical drugs, so it has little influence at present.

Pharmaceutical Company has formulated the "

4 2 " new drug research and development model, focusing on the development of anti-infection, cardiovascular and cerebrovascular, anti-tumor, infant and elderly drugs. It will introduce and reorganize methods to increase Chinese patent medicines. Varieties, and at the same time do a good job in the secondary development of existing varieties, expand the market share of Chinese patent medicines, and gradually realize the parallel development of chemical medicines and Chinese patent medicines.

Reporter: Chinese herbal medicine is one of the three major product lines of Pinnacle Health, will the introduction of the new law have an impact on Pinnacle Health?

Chen Daiyou (General Manager of Pinnacle Health Technology): Under the background of healthy China and benefiting the world, with the introduction of the Chinese Medicine Law, the development of the Chinese medicine industry will enter a new period of development. At present, Chinese medicine is roughly divided into Chinese patent medicine, Chinese herbal medicine and medical institutions homemade Chinese medicine three categories. The promulgation of the new law provides more policy support and conditions for the development of Chinese medicine. With the advancement of the construction of Chinese medicine medical institutions and the injection of more "Chinese medicine elements", the Chinese medicine market will show a better growth trend. The development of healthy Chinese medicine decoction pieces will also enjoy the dividend effect produced by the general environment.

Reporter: The Law of Traditional Chinese Medicine stipulates that the state supports scientific research and technological development of traditional Chinese medicine and encourages scientific and technological innovation of traditional Chinese medicine. The section of Jianfeng Healthy Chinese Herbal Pieces is positioned as "the leader of innovative Chinese herbal pieces", and there are nearly

10 innovative herbal pieces such as freeze-dried Gastrodia elata, freeze-dried Rhizoma Polyza and Astragalus, what are the future research and development considerations in this area?

Chen Daiyou: Jianfeng Health has made certain achievements in the research and development and innovation of new decoction pieces. Integrating enterprise resources, seizing the "golden age" of the development of traditional Chinese medicine and accelerating the industrialization transformation are our main tasks at present. Under the acceleration of the basic scale production and sales of Chinese medicine tablets, Spike Health will pay more attention to the cultivation of key varieties with competitive comparative advantages, and strengthen the expansion of high-end new drink tablets business. Especially with the acceptance and recognition of traditional Chinese medicine by the world, the modernization of traditional Chinese medicine is also an inevitable trend. Traditional Chinese medicine formula particles, nano traditional Chinese medicine and ultra-micro traditional Chinese medicine will become the trend choice of enterprise research and development in the future.

Reporter: The Chinese Medicine Law stipulates that the quality supervision and management of the whole process of the production and circulation of Chinese medicinal materials should be strengthened. How to ensure the quality and safety of products in the selection of raw materials, product production, storage, etc?

Chen Daiyou: With the formulation of national technical specifications and standards for the cultivation, collection, storage and primary processing of Chinese medicinal materials, the establishment of the evaluation system of authentic Chinese medicinal materials, and the establishment of the circulation traceability system of Chinese medicinal materials, the quality and safety of Chinese medicinal materials More guaranteed. The production of Jianfeng Healthy Chinese Herbal Pieces has always been strictly and strictly managed in accordance with

GMP specifications. The quality and safety brand of Jianfeng Healthy Chinese Herbal Pieces has been improved through authentic Chinese herbal medicines, GAP Chinese herbal medicines, automation of production process, improvement of packaging and storage technology of Chinese herbal medicines, etc.

Reporter: As a commercial enterprise, will the promulgation of the new law have an impact on pharmaceutical companies and the product structure of large pharmacies? Is there a corresponding plan for this?

Wu Weisheng (General Manager of Jinhua Pharmaceutical Co., Ltd.): There will definitely be some impact, but the variety composition and inventory structure of comprehensive Chinese herbal pieces and seasonal herbal pieces should not change much. In the future, pharmaceutical companies will mainly increase the processing specifications of some Chinese herbal pieces, look for the purchase channels of some cold-sided real estate Chinese herbal pieces, and at the same time strive to ensure the quality stability of the newly added herbal pieces specifications. Now the pharmaceutical company has reached a preliminary cooperation intention with Jianfeng Health Technology, Tongjuntang Pharmaceutical, Nankong Traditional Chinese Medicine and other companies to ensure the supply of high-quality and high-price products.

He Songqin (General Manager of Peak Pharmacy): It is expected that medical institutions will further expand their investment in Chinese medicine. With the state's support for "prescription drug outflow", the outflow of traditional Chinese medicine prescriptions will gradually increase. Some unpopular traditional Chinese medicines may not have corresponding stocks, and large pharmacies will arrange purchases. Reporter

: The "Traditional Chinese Medicine Law" stipulates that the state encourages the development of a modern circulation system for Chinese medicinal materials. Chinese medicinal materials operators should establish a purchase inspection and purchase and sale record system, and indicate the origin of Chinese medicinal materials. How do pharmaceutical companies do this?

Wu Weisheng: Pharmaceutical companies purchase Chinese herbal medicines in strict accordance with the requirements of the new version

GSP , I .e. the purchase and sale of Chinese herbal medicines and Chinese herbal pieces have corresponding records, and have special personnel to inspect and review them. The label of Chinese herbal pieces is marked with the name, specification, place of origin, batch number, production date, manufacturer and inspection basis. Each batch of finished decoction pieces has an inspection report; chinese herbal medicine labels indicate the origin, quantity and harvest date. At the same time, in order to ensure the acquisition of high-quality Chinese medicinal materials, most pharmaceutical companies now purchase Chinese medicinal materials from real estate Chinese medicine planting cooperatives to ensure the legality and traceability of the purchase channels.

He Songqin: In this regard, the large pharmacy strictly follows the requirements of the drug

GSP specification, and at the same time manages the purchase, sale and storage of traditional Chinese medicine through the computer system, which also fully meets the requirements.

Reporter: Will there be any changes in the arrangement of TCM doctors in the TCM Law to obtain the qualification of TCM doctors?

He Songqin: Previously, TCM sitting clinics were licensed, but with the change of TCM sitting clinics to filing system, large pharmacies will usher in new development opportunities. In the future, large pharmacies will actively introduce qualified sitting doctors to improve the competitiveness of enterprises; at the same time, for the sustainable development of enterprises, large pharmacies will try to directly introduce talents and train their own sitting doctors.

reporter: The "Traditional Chinese Medicine Law" stipulates that the competent department of medicine should strengthen the supervision and inspection of Chinese medicine services. Do large pharmacies have corresponding systems and measures to regulate this service?

He Songqin: Over the years, large pharmacies have adhered to the business policy of "standardized management, characteristic service, quality first, and establishing a peak brand", and have withstood various supervision and inspection by the pharmaceutical authorities. In the future, large pharmacies will continue to adhere to the business policy, strictly control the quality of Chinese herbal pieces, and strictly follow the requirements of Chinese herbal decoction to decoct medicines on behalf of customers, so as to improve the effect of Chinese medicine diagnosis and treatment, and at the same time learn and learn from the advanced experience of peers to strengthen and expand Chinese medicine. Characteristic service. (Reporter

Ni Yingzhen)